Reducing or inhibiting the PGK1 signaling pathway could significantly enhance radiosensitivity and inhibit tumor growth, which is a rational method to improve the outcome of radiotherapy and chemotherapy just by PGK1 silencing [23, 24]. The gene discussed is PGK1; the disease is neoplasm.